Focus Financial Network’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Sell
2,032
-598
-23% -$89.6K 0.01% 601
2026
Q1
$402K Sell
2,630
-330
-11% -$50.6K 0.01% 520
2025
Q4
$408K Sell
2,960
-216
-7% -$28.3K 0.01% 500
2025
Q3
$407K Sell
3,176
-7
-0.2% -$854 0.01% 507
2025
Q2
$385K Buy
3,183
+182
+6% +$20.5K 0.02% 497
2025
Q1
$335K Sell
3,001
-54
-2% -$5.75K 0.01% 521
2024
Q4
$297K Sell
3,055
-30
-1% -$3.2K 0.01% 553
2024
Q3
$355K Buy
3,085
+15
+0.5% +$1.7K 0.01% 496
2024
Q2
$343K Buy
+3,070
New +$308K 0.01% 490
2021
Q4
Sell
-2,673
Closed -$219K 418
2021
Q3
$219K Buy
2,673
+249
+10% +$22.4K 0.03% 385
2021
Q2
$221K Sell
2,424
-120
-5% -$10.7K 0.03% 383
2021
Q1
$217K Buy
+2,544
New +$228K 0.03% 379

Other funds holding NVS

Focus Financial Network's NVS Position: Q2 2026 in Review

Focus Financial Network reduced its Novartis (NVS) stake by 23% in Q2 2026, selling an estimated $89.6K and leaving 2,032 shares worth $318K. The position accounts for 0.01% of the portfolio, ranked #601.

Focus Financial Network first reported a position in NVS in Q1 2021 and has held it in 12 quarters since. The position peaked at $408K in Q4 2025. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Focus Financial Network held 2,032 shares of Novartis worth $318K as of Q2 2026.
  • Focus Financial Network sold 598 Novartis shares in Q2 2026, an estimated $89.6K.
  • Novartis made up 0.01% of Focus Financial Network's portfolio in Q2 2026, its #601 holding.
  • Focus Financial Network first reported a position in Novartis in Q1 2021 and has held it in 12 quarters since.
  • Focus Financial Network's Novartis position peaked at $408K in Q4 2025.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Focus Financial Network's 13F filing for Q2 2026, filed 9 Jul 2026.